Megestrol acetate dispersible tablets with a 5-HT3 receptor antagonist and dexamethasone <i>vs.</i> 5-HT3 receptor antagonist plus dexamethasone, can better control chemotherapy-induced nausea and vomiting: a randomized controlled study.

导出 LinkOut

翻译打印收藏纠错

作者： Yijie,Ma ^[1] ; Weijie,Zhao ^[2] ; Wenying,Deng ^[1] ; Chen,Wei ^[1] ; Liangyu,Bie ^[1] ; Chi,Zhang ^[1] ; Ning,Li ^[1] ; Suxia,Luo ^[1]

作者单位： Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. ^[1] Department of General Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. ^[2]

关键词 Chemotherapy-induced nausea and vomiting (CINV)chemotherapy cisplatin megestrol quality of life (QOL)

DOI 10.21037/atm-22-4809

PMID 36388808

发布时间 2023-09-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of translational medicine

2022年10卷20期

1124页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Megestrol acetate dispersible tablets with a 5-HT3 receptor antagonist and dexamethasone <i>vs.</i> 5-HT3 receptor antagonist plus dexamethasone, can better control chemotherapy-induced nausea and vomiting: a randomized controlled study.

Annals of translational medicine

相似文献

Annals of translational medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Megestrol acetate dispersible tablets with a 5-HT3 receptor antagonist and dexamethasone <i>vs.</i> 5-HT3 receptor antagonist plus dexamethasone, can better control chemotherapy-induced nausea and vomiting: a randomized controlled study.

Annals of translational medicine

相似文献

Annals of translational medicine

相关期刊

检索历史清除